Evaluation status available after sign-in
About the journal
Cancer Innovation is an open-access journal published by Wiley in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,700 USD. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Wiley
- ISSN
- 2770-9191 · 2770-9183
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,700 USD
- Articles in DOAJ
- 181
- Declared review time
- 12 weeks
- Declared peer-review model
- other
- Official website
- https://onlinelibrary.wiley.com/journal/27709183
Index listings
- DOAJ · 2022-10-27
- Indexing
- DOAJ
- APC
- 2,700 USD
- Declared review time (DOAJ)
- 12 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
181
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
12weeks
Works in OpenAlex
260
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
17
i10-index
32
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2022-10-27
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPorticoPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 79%
- ORCID iDs in current deposits
- 74%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918713888606676
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
LCC codes
RC254-282
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Breast Cancer Treatment Studies
- Lung Cancer Treatments and Mutations
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- Ferroptosis and cancer prognosis
Show all subjects (75)
- Ferroptosis and cancer prognosis
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Diverse Scientific and Economic Studies
- Educational Robotics and Engineering
- Educational Robotics and Engineering
- Human auditory perception and evaluation
- Diverse Scientific and Economic Studies
- Human auditory perception and evaluation
- Radiomics and Machine Learning in Medical Imaging
- Immunotherapy and Immune Responses
- Advanced Breast Cancer Therapies
- Advanced Breast Cancer Therapies
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Gastric Cancer Management and Outcomes
- Radiomics and Machine Learning in Medical Imaging
- Radiomics and Machine Learning in Medical Imaging
- HER2/EGFR in Cancer Research
- Cancer Genomics and Diagnostics
- Breast Lesions and Carcinomas
- Ferroptosis and cancer prognosis
- Advanced Breast Cancer Therapies
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- AI in cancer detection
- AI in cancer detection
- AI in cancer detection
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- Immunotherapy and Immune Responses
- CAR-T cell therapy research
- Immunotherapy and Immune Responses
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Cancer Cells and Metastasis
- Global Cancer Incidence and Screening
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Lung Cancer Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Artificial Intelligence in Healthcare and Education
- Cancer Treatment and Pharmacology
- Glioma Diagnosis and Treatment
- Delphi Technique in Research
- Cancer Genomics and Diagnostics
- Delphi Technique in Research
- Cancer Treatment and Pharmacology
- Global Cancer Incidence and Screening
- Global Cancer Incidence and Screening
- RNA modifications and cancer
- Circular RNAs in diseases
- Cancer-related molecular mechanisms research
- RNA modifications and cancer
- Circular RNAs in diseases
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Cancer-related molecular mechanisms research
- Glioma Diagnosis and Treatment
- Head and Neck Cancer Studies
- Chemotherapy-induced cardiotoxicity and mitigation
- Pancreatic and Hepatic Oncology Research
- Sarcoma Diagnosis and Treatment
- Genetic Associations and Epidemiology
Keywords (DOAJ)
- oncology
- medical engineering
- translational medicine
- computational science
- tumour multiomics
- carcinogenesis
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ